TCR2 THERAPEUTICS INC (TCRR) Stock Balance Sheet
NASDAQ:TCRR - Nasdaq - US87808K1060 - Common Stock - Currency: USD
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 14.45M | 32.75M | 222.56M | 94.20M | 65.30M | |||
| Marketable Securities | 95.86M | 116.43M | 43.03M | 133.80M | 92.80M | |||
| Other Current Assets | 30.18M | 28.44M | 10.53M | 7.60M | 5.10M | |||
| Total Current Assets | 140.49M | 177.62M | 276.13M | 235.50M | 163.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.15M | 28.68M | 45.36M | 10.00M | 4.90M | |||
| Other Non-Current Assets | 1.87M | 1.94M | 1.89M | 600.00K | 400.00K | |||
| Total Non-Current Assets | 11.02M | 30.61M | 47.24M | 10.70M | 5.30M | |||
| TOTAL ASSETS | 151.51M | 208.24M | 323.37M | 246.20M | 168.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 38.11M | 60.73M | 16.05M | 6.20M | 4.80M | |||
| Accounts Payable | 6.32M | 2.79M | 2.14M | 2.40M | 2.50M | |||
| Other Current Liabilities | 3.04M | 533.00K | 413.00K | 200.00K | 300.00K | |||
| Total Current Liabilities | 47.47M | 64.06M | 18.61M | 8.80M | 7.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.71M | 3.32M | 23.29M | 800.00K | 500.00K | |||
| Total Non-Current Liabilities | 2.71M | 3.32M | 23.29M | 800.00K | 600.00K | |||
| TOTAL LIABILITIES | 50.18M | 67.38M | 41.89M | 9.60M | 8.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -541.74M | -501.34M | -349.52M | -249.70M | -182.60M | |||
| Additional Paid In Capital | 643.26M | 642.64M | 631.01M | 486.20M | 342.90M | |||
| Common Shares | 4.00K | 4.00K | 4.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -188.00K | -445.00K | -13.00K | 100.00K | 100.00K | |||
| Shares Outstanding | 39.24M | 39.20M | 38.50M | 33.50M | 24.00M | |||
| Tangible Book Value per Share | 2.58 | 3.59 | 7.31 | 7.06 | 6.68 | |||
| Total Shareholders' Equity | 101.33M | 140.86M | 281.48M | 236.50M | 160.40M | |||
| TOTAL LIABILITIES AND EQUITY | 151.51M | 208.24M | 323.37M | 246.20M | 168.50M | |||
| Statistics | ||||||||
| Current Ratio | 2.96 | 2.77 | 14.84 | 26.76 | 21.76 | |||
| Return On Assets (ROA) | -107.65% | -72.91% | -30.86% | -27.26% | -57.86% | |||
| Return On Equity (ROE) | -160.96% | -107.78% | -35.46% | -28.38% | -60.79% | |||
All data in USD , ROIC based on taxRate of 0.21